An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
Jayqwan Hamilton, 37, Robert DeMaio, 36, and Jacob Barroso, 32 -- shuffled into a Manhattan courtroom for the first day of a ...
Exelixis, Inc. (NASDAQ:EXEL), currently trading near $33, continues to build on the success of its flagship product ...
A little-known arm of the National Institutes of Health (NIH) has directed over $1 billion into “sexual and gender minority” ...
Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...
The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...
Three men have been accused of murder as part of a plot to drug and rob revelers in Midtown in 2022. Two of their targets ...
President Donald Trump's initial executive orders target previous efforts to reduce health care costs, pandemic preparedness, ...
Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...
Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...
Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback